AAAAAA
Results:
1-14
|
Results: 14
Authors:
Miwa, H
Akamatsu, S
Tachikawa, T
Sogabe, T
Ohtaka, K
Nagahara, A
Sugiyama, Y
Sato, N
Citation: H. Miwa et al., On-site diagnosis of H-pylori infection by urine, DIAG MICR I, 39(2), 2001, pp. 95-97
Authors:
Nagahara, A
Miwa, H
Yamada, T
Kurosawa, A
Ohkura, R
Sato, N
Citation: A. Nagahara et al., Five-day proton pump inhibitor-based quadruple therapy regimen is more effective than 7-day triple therapy regimen for Helicobacter pylori infection, ALIM PHARM, 15(3), 2001, pp. 417-421
Authors:
Miwa, H
Misawa, H
Yamada, T
Nagahara, A
Ohtaka, K
Sato, N
Citation: H. Miwa et al., Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H-pylori infection - A multiple logistic regression analysis, DIG DIS SCI, 46(11), 2001, pp. 2445-2450
Authors:
Hojo, M
Miwa, H
Nagahara, A
Sato, N
Citation: M. Hojo et al., Pooled analysis on the efficacy of the second-line treatment regimens for Helicobacter pylori infection, SC J GASTR, 36(7), 2001, pp. 690-700
Authors:
Nagahara, A
Miwa, H
Ogawa, K
Kurosawa, A
Ohkura, R
Iida, N
Sato, N
Citation: A. Nagahara et al., Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy, HELICOBACT, 5(2), 2000, pp. 88-93
Authors:
Miwa, H
Murai, T
Sato, K
Ohkura, R
Yamada, T
Nagahara, A
Ohtaka, K
Minowa, T
Kurosawa, A
Sato, N
Citation: H. Miwa et al., Comparison of the efficacy of 400 mg and 800 mg of clarithromycin used with lansoprazole and amoxicillin in eradication regimens for Helicobacter pylori infection in a Japanese population, J GASTRO, 35(7), 2000, pp. 536-539
Authors:
Miwa, H
Kikuchi, S
Ohtaka, K
Kobayashi, O
Ogihara, A
Hojo, M
Nagahara, A
Sato, N
Citation: H. Miwa et al., Insufficient diagnostic accuracy of imported serological kits for Helicobacter pylori infection in Japanese population, DIAG MICR I, 36(2), 2000, pp. 95-99
Authors:
Miwa, H
Hirai, S
Nagahara, A
Murai, T
Nishira, T
Kikuchi, S
Takei, Y
Watanabe, S
Sato, N
Citation: H. Miwa et al., Cure of Helicobacter pylori infection does not improve symptoms in non-ulcer dyspepsia patients - a double-blind placebo-controlled study, ALIM PHARM, 14(3), 2000, pp. 317-324
Authors:
Murai, T
Miwa, H
Ohkura, R
Iwazaki, R
Nagahara, A
Sato, K
Yamada, T
Ota, K
Tanaka, H
Kawabe, M
Minowa, T
Takei, Y
Miyazaki, A
Sato, N
Citation: T. Murai et al., The incidence of reflux oesophagitis after cure of Helicobacter pylori in a Japanese population, ALIM PHARM, 14, 2000, pp. 161-165
Authors:
Miwa, H
Yamada, T
Sato, K
Ohta, K
Ohkura, R
Murai, T
Nagahara, A
Takei, Y
Ogihara, T
Sato, N
Citation: H. Miwa et al., Efficacy of reduced dosage of rabeprazole in PPI/AC therapy for Helicobacter pylori infection - Comparison of 20 and 40 mg rabeprazole with 60 mg lansoprazole, DIG DIS SCI, 45(1), 2000, pp. 77-82
Authors:
Ohkura, R
Miwa, H
Murai, T
Nagahara, A
Ohta, K
Sato, K
Yamada, T
Sato, N
Citation: R. Ohkura et al., Usefulness of a novel enzyme immunoassay for the detection of Helicobacterpylori in feces, SC J GASTR, 35(1), 2000, pp. 49-53
Authors:
Miwa, H
Nagahara, A
Sato, K
Ohkura, R
Murai, T
Shimizu, H
Watanabe, S
Sato, N
Citation: H. Miwa et al., Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population, J GASTR HEP, 14(4), 1999, pp. 317-321
Authors:
Miwa, H
Ohkura, R
Murai, T
Sato, K
Nagahara, A
Hirai, S
Watanabe, S
Sato, N
Citation: H. Miwa et al., Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection - comparison with omeprazole and lansoprazole, ALIM PHARM, 13(6), 1999, pp. 741-746
Authors:
Miwa, H
Ohkura, R
Nagahara, A
Murai, T
Ogihara, T
Watanabe, S
Hirai, S
Sato, N
Citation: H. Miwa et al., [C-13]-urea breath test for assessment of cure of Helicobacter pylori infection at 1 month after treatment, J CLIN GAST, 27, 1998, pp. S150-S153
Risultati:
1-14
|